Did you hear about that hot IPO? Do you know the company's enterprise value? Do you use the XIRR function on your spreadsheet to track your investments? Does this sound like a motley bunch of questions crammed together to pique your interest? Must be mailbag time again!
You can’t invest in Beanie Babies, but you can invest in more than just stocks and bonds in your IRA. Eric Satz of AltoIRA joins us to discuss alternative investing options for your retirement accounts.
What’s one stock that sparks joy? What’s one stock that should be thrown out? What’s a highflier that investors should consider trimming? On this week’s Motley Fool Money Spring Cleaning Special, analysts Andy Cross, Ron Gross, and Jason Moser tackle those questions and share some of their favorite cleaning tips. Plus, best-selling author Daniel Levitin shares some thoughts from his book, The Organized Mind: Thinking Straight in the Age of InformationOverload.
iRobot’s 1st-quarter profits came in higher than expected, but shares are falling 20%. Ron Gross analyzes the results and shares how looking past the headline can explain iRobot’s rough day. Domino’s Pizza shares pop despite the slowest same-store sales growth in more than 5 years. Plus, we dip into the Fool Mailbag to discuss the link between market highs and IPO offerings. Thanks to Molekule for supporting our podcast. Get $75 off your 1st order at http://www.molekule.com and use the promo code “fool75”.
An infant participating in Novartis' Zolgensma trial has died, raising questions ahead of an expected FDA decision next month for this one-and-done treatment for spinal muscular atrophy. Here's what you should know. Also, why investors should ignore Intuitive Surgical's first quarter earnings miss and buy shares on sale.
Get more great information on becoming a better investor -- free and straight to your inbox!
By submitting your email address, you consent to us keeping you informed about updates to our website and about other products and services that we think might interest you. You can unsubscribe at any time. Please read our Privacy Statement and Terms & Conditions.